China SXT Pharmaceuticals, Inc. (NASDAQ:SXTC) Sees Significant Growth in Short Interest

China SXT Pharmaceuticals, Inc. (NASDAQ:SXTCGet Free Report) was the target of a large growth in short interest during the month of December. As of December 31st, there was short interest totalling 377,600 shares, a growth of 44.1% from the December 15th total of 262,000 shares. Approximately 11.0% of the company’s stock are short sold. Based on an average daily trading volume, of 1,060,000 shares, the days-to-cover ratio is presently 0.4 days.

China SXT Pharmaceuticals Price Performance

NASDAQ:SXTC traded up $0.01 during trading hours on Friday, hitting $0.42. 9,310 shares of the company traded hands, compared to its average volume of 740,601. The firm’s 50-day simple moving average is $0.42 and its 200-day simple moving average is $0.68. China SXT Pharmaceuticals has a one year low of $0.30 and a one year high of $3.37.

About China SXT Pharmaceuticals

(Get Free Report)

China SXT Pharmaceuticals, Inc, a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China. The company offers advanced, fine, and regular TCMP products, and raw medicinal material, such as ChenXiang, SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, and ShaRen.

See Also

Receive News & Ratings for China SXT Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for China SXT Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.